Pharmaceutical

STAT+: Pharmalittle: We’re reading about FDA warnings o...

The FDA is requiring manufacturers of CAR-T cancer therapies to add a serious wa...

White House pharmacy under the microscope

This week's D.C. Diagnosis newsletter digs into troubles at the White House's ph...

Mammograms are less effective for women with dense brea...

While it’s well known that dense breast tissue can make mammograms less effectiv...

STAT+: Pharma’s attack on Medicare drug price negotiati...

All those lawsuits against Biden's signature achievement of Medicare drug price ...

The White House has a pharmacy — and it was a mess, a n...

The White House pharmacy was doling out drugs without much regard for pharmacy r...

Opinion: It’s time to remove skin color from the Apgar ...

The Apgar Score for newborns has saved countless lives. But it’s time for a change.

Abortion funds run short of money as demand soars and d...

Some abortion funds went from supporting 100 abortions a month to 100 a week. Wi...

Bayer in artificial intelligence: theme innovation stra...

How many patents did Bayer submit related to artificial intelligence last quarte...

Genentech signs nanoparticle deal worth up to $644m wit...

Genentech will utilise GenEdit’s non-viral polymer nanoparticles for gene therap...

Sanofi signs agreement to acquire Inhibrx for $1.7bn

Sanofi has signed a definitive agreement for the acquisition of all outstanding ...

Inhalation Sciences and Actarmo enter respiratory drugs...

Inhalation Sciences has entered into a collaboration with Germany-based Actarmo ...

UK MHRA strengthens regulations on fluoroquinolone anti...

The UK MHRA has introduced further restrictions on the usage of fluoroquinolone ...

NS Pharma gains EC orphan drug designation to treat EGPA

NS Pharma has received orphan drug designation from the European Commission for ...

A ‘sense of urgency’ swirls in the UK pharma regulatory...

The UK government adopted a series of updates to pharmaceutical laws, governing ...

F. Hoffmann-La Roche in cybersecurity: theme innovation...

How many patents did F. Hoffmann-La Roche submit related to cybersecurity last q...

Cara Therapeutics cuts 50% of staff and drops kidney di...

The company ceased activity for its CKD program to sharpen its clinical focus in...